Treatment with dupilumab demonstrated improvements in histological markers, symptoms, and endoscopic markers of eosinophilic esophagitis (EoE) regardless of previous history of esophageal dilation. In ...

The study was conducted because information on the relationship between eosinophilic esophagitis (EOE) symptoms and biologic findings are limited, so researchers looked at the long-term effects of ...

Woman eating healthy food, selective focus, canon 1Ds mark III Researchers sought to identify clinical and endoscopic factors that would affect patients’ ability to achieve a normal diet after ...

Achalasia is a syndrome of esophageal dysmotility characterized by failure of relaxation of the lower esophageal sphincter (LES) and lack of functional peristalsis in the body. All current forms of ...

Achalasia is a disease caused by impaired movement of the esophagus. Patients experience food getting stuck and regurgitated, as well as chest pain. Currently, upper gastrointestinal endoscopy and ...

Researchers from Children's Hospital of Philadelphia (CHOP) and Children's Hospital Colorado have found that better control of chronic eosinophilic esophagitis (EoE)-associated inflammation during ...

A 39-year-old Thai pregnant woman, G5P2-0-2-2, was referred to our hospital at 33 weeks of gestation due to progressive dysphagia. The symptom started from 18 weeks of gestation. Her first two ...

If you have a new diagnosis of eosinophilic esophagitis (EoE), you’ll want to know what the best treatment is for you. The mainstays of treatment for EoE are proton pump inhibitors, steroids, diet ...

Please provide your email address to receive an email when new articles are posted on . Other eosinophilic esophagitis treatments may have painful side effects. Dupilumab improved histologic, ...

An esophageal stricture is a narrowing of the esophagus, often caused by scarring or inflammation. It can lead to difficulty swallowing, chest pain, and the regurgitation of food or liquids. It is ...

Management of esophageal carcinoma is based on tumor extent according to the TNM classification; it is divided into curatively and palliatively intended treatment. Patients with locoregional disease ...

CHICAGO — Dupilumab significantly improved esophageal distensibility and diameter in eosinophilic esophagitis at 24 weeks, alongside marked gains in endoscopic and histologic disease outcomes, data ...